Literature DB >> 20975608

Letter to the editor.

Robert Brunner1.   

Abstract

Entities:  

Year:  2010        PMID： 20975608      PMCID： PMC3883461          DOI： 10.1097/gme.0b013e3181f7dd34

Source DB:  PubMed          Journal:  Menopause        ISSN： 1072-3714            Impact factor:   2.953


× No keyword cloud information.
  6 in total

1.  Menopausal symptom experience before and after stopping estrogen therapy in the Women's Health Initiative randomized, placebo-controlled trial.

Authors:  Robert L Brunner; Aaron Aragaki; Vanessa Barnabei; Barbara B Cochrane; Margery Gass; Susan Hendrix; Dorothy Lane; Judith Ockene; Nancy F Woods; Shagufta Yasmeen; Marcia Stefanick
Journal:  Menopause       Date:  2010 Sep-Oct       Impact factor: 2.953

2.  Effects of conjugated equine estrogen on health-related quality of life in postmenopausal women with hysterectomy: results from the Women's Health Initiative Randomized Clinical Trial.

Authors:  Robert L Brunner; Margery Gass; Aaron Aragaki; Jennifer Hays; Iris Granek; Nancy Woods; Ellen Mason; Robert Brzyski; Judith Ockene; Annlouise Assaf; Andrea LaCroix; Karen Matthews; Robert Wallace
Journal:  Arch Intern Med       Date:  2005-09-26

3.  Effects of estrogen plus progestin on health-related quality of life.

Authors:  Jennifer Hays; Judith K Ockene; Robert L Brunner; Jane M Kotchen; JoAnn E Manson; Ruth E Patterson; Aaron K Aragaki; Sally A Shumaker; Robert G Brzyski; Andrea Z LaCroix; Iris A Granek; Barbara G Valanis
Journal:  N Engl J Med       Date:  2003-03-17       Impact factor: 91.245

4.  Prescribing postmenopausal hormone therapy to women in their 50s in the post-Women's Health Initiative era.

Authors:  Jacques E Rossouw
Journal:  Maturitas       Date:  2009-12-09       Impact factor: 4.342

5.  Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease.

Authors:  Miguel A Hernán; Alvaro Alonso; Roger Logan; Francine Grodstein; Karin B Michels; Walter C Willett; Joann E Manson; James M Robins
Journal:  Epidemiology       Date:  2008-11       Impact factor: 4.822

6.  Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause.

Authors:  Ross L Prentice; Joann E Manson; Robert D Langer; Garnet L Anderson; Mary Pettinger; Rebecca D Jackson; Karen C Johnson; Lewis H Kuller; Dorothy S Lane; Jean Wactawski-Wende; Robert Brzyski; Matthew Allison; Judith Ockene; Gloria Sarto; Jacques E Rossouw
Journal:  Am J Epidemiol       Date:  2009-05-25       Impact factor: 4.897
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.